Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Barrett to lead Pulse as CEO

Plus: Anumana hires Harry Palmin as CFO, and new SVP of regulatory at Nanoscope 

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst  
May 14, 2024 11:27 PM UTC

Pulse Biosciences Inc. (NASDAQ:PLSE) named Burke Barrett as president and CEO, succeeding Kevin Danahy, who will become chief commercial officer. Barrett was president and CEO of CardioFocus Inc.

Cardiovascular diagnostic play Anumana Inc. hired Harry Palmin as CFO. Palmin was CFO at Acer Therapeutics Inc. Palmin also became CFO of Ventures at nference Inc., which co-founded Anumana alongside Mayo Clinic...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Anumana Inc.

Nanoscope Therapeutics Inc.

Nouscom AG